Second-line chemotherapy in advanced biliary cancer: the present now will later be past.

Vivaldi, C; Fornaro, L; Cereda, S; Aprile, G; Santini, D; Silvestris, N; Lonardi, S; Leone, F; Milella, M; Brandi, G; Vasile, E

Vivaldi, C; Fornaro, L; Cereda, S; Aprile, G; Santini, D; Silvestris, N; Lonardi, S; Leone, F; Milella, M; Brandi, G; Vasile, E.

Afiliação

Vivaldi C; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa.
Fornaro L; Unit of Medical Oncology, Azienda USL2 Lucca, Lucca.
Cereda S; Department of Medical Oncology, San Raffaele Scientific Institute, Milan.
Aprile G; Department of Oncology, University and General Hospital, Udine.
Santini D; Department of Medical Oncology, University Campus Bio-Medico, Rome.
Silvestris N; Unit of Medical Oncology, National Cancer Institute Giovanni Paolo II, Bari.
Lonardi S; Unit of Medical Oncology 1, Istituto Oncologico Veneto, IRCCS, Padova.
Leone F; Unit of Medical Oncology, Institute for Cancer Research and Treatment IRCCS Candiolo, University of Torino, Turin.
Milella M; Medical Oncology A, Regina Elena National Cancer Institute, Rome.
Brandi G; Unit of Medical Oncology, Sant'Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
Vasile E; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa;. Electronic address: envasile@tin.it.

Ann Oncol ; 25(12): 2443-2444, 2014 Dec.

Article em En | MEDLINE | ID: mdl-25122694

Assuntos

Antineoplásicos/uso terapêutico; Neoplasias do Sistema Biliar/tratamento farmacológico; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google